Investor mix
9 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Private equity | 2 | 22% |
| Other / undisclosed | 1 | 11% |
Inhaled therapeutics for the treatment of cardiopulmonary diseases.
9 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 67% |
| Private equity | 2 | 22% |
| Other / undisclosed | 1 | 11% |